Estimating outcome probabilities from early symptom changes in cognitive therapy for recurrent depression

Area of Science:

• Psychiatry
• Clinical Psychology

Background:

• Cognitive therapy (CT) is an effective treatment for major depressive disorder (MDD).
• However, not all patients achieve full remission or respond adequately to CT.
• Predicting treatment outcomes early can inform clinical decision-making.

Purpose of the Study:

• To estimate the probability of nonresponse and remission in patients undergoing acute-phase CT for MDD.
• To determine if early symptom improvement predicts treatment outcomes.

Main Methods:

• Pooled data from 679 adult outpatients in 2 clinical trials of CT for recurrent depression.
• Symptoms assessed using Hamilton Rating Scale for Depression (HRSD) and Inventory of Depressive Symptomatology-Self-Report (IDS-SR).
• Nonresponse defined as <50% HRSD reduction; remission as no MDD and HRSD ≤6.

Main Results:

• The overall nonresponse rate was 45.7%, and the remission rate was 33.4%.
• Early symptom improvements (by session 11) significantly predicted both nonresponse and remission.
• Patients showing no improvement by CT Session 9 (Week 5) had a ≤10% chance of remission and >75% chance of nonresponse.

Conclusions:

• Treatment outcomes for CT in MDD are predictable based on early symptom changes.
• These predictions can assist clinicians in discussions about treatment expectations and adjustments.
• Estimates of nonresponse and remission probabilities can guide decisions on continuing, augmenting, or switching treatments.